Veterinary Medicines

MILBEMAX 2.5 MG/25 MG CHEWABLE TABLETS FOR SMALL DOGS AND PUPPIES

Authorised
  • Milbemycin oxime
  • Praziquantel
Download as PDF

Product identification

Medicine name:
MILBEMAX 2.5 MG/25 MG CHEWABLE TABLETS FOR SMALL DOGS AND PUPPIES
Milbemax voor kleine honden en puppys 2.5 mg - 25 mg Kauwtablet
Milbemax voor kleine honden en puppys 2.5 mg - 25 mg Comprimé à croquer
Milbemax voor kleine honden en puppys 2.5 mg - 25 mg Kautablette
Active substance:
  • Milbemycin oxime
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    2.50
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    25.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 1 box with 1 blister of 2 chewable tablets
  • 1 box with 12 strips, each strip contains 4 chewable tablets
  • 1 box with 12 blisters, each blister contains 4 chewable tablets
  • 1 box with 1 strip of 4 chewable tablets
  • 1 box with 1 strip of 2 chewable tablets
  • 1 box with 1 blister of 4 chewable tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0135/005
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/01/2025
Download
French (PDF)
Published on: 15/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/01/2025
Download
French (PDF)
Published on: 15/01/2025
Download
German (PDF)
Published on: 15/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 15/01/2025
Download
French (PDF)
Published on: 15/01/2025
Download
German (PDF)
Published on: 15/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."